| Latest Forum Topics / Biosensors |
 Post Reply
|
|
Is Biosensors a good buy?
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hulumas
Supreme |
28-May-2010 15:03
Yells: "INVEST but not TRADE please!" |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
From the price level, good news has been priced in!
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
XiaoMaGe888
Senior |
27-May-2010 09:25
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
BIG is the most "LP" counter. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
topdog22
Senior |
26-May-2010 23:57
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Clinical Results GREAT!!! How will investors view the stock now? BIG exceeded concensus numbers and had great clinical success. Trials proved stent better than JNJ & Boston Scientific established stents. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
XiaoMaGe888
Senior |
26-May-2010 18:12
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
http://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_E4167B6FC5AAC26F4825772F001EBEFE/$file/BIG_4QFY2010_PressRelease.pdf | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
lostbell
Member |
26-May-2010 14:13
Yells: "GOD BLESS EVERYONE!!!" |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Biosensors press notice http://biosensors.listedcompany.com/newsroom/20100526_123843_B20_EAAD7DCC070A3DC84825772F00193718.1.pdf |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
XiaoMaGe888
Senior |
26-May-2010 09:23
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
So Boss , how Clinical Results good or not?
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
topdog22
Senior |
25-May-2010 22:59
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Nobori Clinical Results Presented 5/25 15 Conclusions 1. NOBORI 1 Clinical Trial met its primary endpoint in both phases showing non-inferiority of Nobori verus Taxus Express and Taxus Liberté with respect to in-stent late loss 2. Most angiographic and IVUS parameters (diameter stenosis instent, mean plaque area and volume and volume obstraction) significantly favoured Nobori stent 3. Angiographic restenosis rate was significantly lower in Nobori vs Taxus (0.4% vs 4.6%; p<0.01) 4. Clinical efficacy and safety of Nobori stent up to 2 years is reflected by: a. Absence of clinically driven TLR b. Low TVF Rate
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
XiaoMaGe888
Senior |
24-May-2010 08:25
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Biosensors Launches BioMatrix Flex™ Drug-Eluting Stent Singapore 24 May 2010 – Biosensors International Group, Ltd (“Biosensors” or the “Company”, Bloomberg : BIG SP) today announced the launch of its BioMatrix Flex™ drug-eluting stent system in major European markets and selected regions in the Middle East, Africa and Asia. An extension of the company’s BioMatrix™ drug-eluting stent system, the BioMatrix Flex™ stent has received CE Mark approval for a comprehensive range of indications, including STEMI (ST Elevated Myocardial Infarction), Acute Coronary Syndromes and Diabetes Mellitus. The BioMatrix Flex™ stent incorporates a new stent platform which combines a curved strut connector with the established Quadrature Link™ design of the existing platform. The unique combination of a Biosensors-developed abluminal biodegradable polymer and proprietary limus drug, Biolimus A9™ (BA9™), pioneered with the BioMatrix™ stent, remains unchanged. The BioMatrix Flex™ stent has also removed the need for a primer coating to adhere the polymer and drug to the stent, with a Biosensors’ proprietary process now applying the polymer and drug directly onto the stent struts. “Since launching BioMatrix in 2008, Biosensors has helped physicians around the world offer improved treatment options to patients suffering from complex cardiovascular disease,” said Jeffrey B. Jump, Managing Director of Biosensors Europe. “With BioMatrix Flex, we are continuing our commitment to develop innovative medical products that help improve patients’ lives.” The BioMatrix Flex™ stent has been studied extensively in both pre-clinical and clinical settings, including the groundbreaking 1,707-patient LEADERS study, the results of which were published in The Lancet in October 2008. In that trial, the first head-to-head randomized trial between two drug-eluting stent systems in a ‘real world, all comers’ population using a clinical primary endpoint, the BioMatrix Flex™ stent demonstrated equivalent safety and efficacy to the Cypher® Select™ stent, based on ninemonth clinical and angiographic follow-up data. In the two-year LEADERS results, presented at the Transcatheter Cardiovascular Therapeutics conference (TCT) in September 2009, the BioMatrix Flex™ stent continued to demonstrate equivalent safety and efficacy as compared to the Cypher® Select™ stent, with an increasing trend towards a long-term safety benefit in favor of the BioMatrix Flex™ stent. Further significant new data from LEADERS is to be presented at EuroPCR, as part of the Hot Line 1 Late Breaking Registries and Trial Update session on 25 May. | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
iPunter
Supreme |
19-May-2010 23:12
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Things look promising for this one, though...  |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
topdog22
Senior |
19-May-2010 23:07
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
I guess it "show time" for BIG. Will they give us a "really BIG show"? Based on all that has transpired, I believe (as previously stated) that there will be an earnings surprise to the upside causing the target price to be revalued to more than $1.25. That the Terumo trial results will be excellent proving the BIG stent to be a clinical outcome leader. That the trading range of BIG will finally return to $1.00+ based on a growing "business as usual". If BIG has additional insight into how it WILL enhance shareholder value, either through the: 1) spin-off of its JWMS JV, by Floating that JV in HongKong or Shanghai and the distribution of those shares to current BIG shareholders, worth .50+ per BIG share 2) an M&A for BIG, worth $1.10++ per BIG Share 3) BIG lisiting on Hong Kong or Shang Hai or U.S. worth $1.10+++ BIG shares could once again recapture the momentum they had in the Spring of 2006. Only another few days for the BIG unveiling. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
iPunter
Supreme |
19-May-2010 14:48
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Are they at the Shanghai Expo?...
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
investor
Senior |
19-May-2010 14:39
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Biosensors progam at the EuroPcr meeting in Paris from 25th May. Visit us at our booths...
Late Breaking Trial
Attend our Symposium
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
iPunter
Supreme |
19-May-2010 09:15
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Lai ya! ... 
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
XiaoMaGe888
Senior |
19-May-2010 09:12
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Is true la!!!!!Get ready to Chiong !!!!!!!!!!!!!!!!!!!!!!!!!!!
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
susan66
Master |
18-May-2010 23:11
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
I think so too, it's just a matter of time. After the surge last Thursday from 0.77 to 0.825, it has been preparing for the next one. These few days very stable when market sentiment poor but managed to support >0.80. So can get ready liao! 
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
iPunter
Supreme |
18-May-2010 15:13
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
lai ya.!... |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
XiaoMaGe888
Senior |
18-May-2010 15:06
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
BIG!!!!!!!!!!!!!!!!!Lai Loh!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hulumas
Supreme |
17-May-2010 21:00
Yells: "INVEST but not TRADE please!" |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
As long as profit is okay to me! Ha. ha.. ha...
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
investor
Senior |
17-May-2010 18:30
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
In Terumo's audio conference on 12th May 2010, they mentioned that sales in Europe, Asia have increase for their interventional cardiology section, which includes Nobori DES, their own cathethar, etc. They specifically mentioned that Nobori has increased sales, which contribute to the results. - No mention of quantum of increase, and whether it is a Q-on-Q increase or Yr-on-YR increase. Are we also able to extrapolate that Biosensors' own bio-matrix sales have also increased ? (Any body got any ideas ?) For info. Not a call to buy/sell. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
investor
Senior |
14-May-2010 22:59
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 1
x 0 Alert Admin |
Probably. one of the reasons, why Biosensors started to move yesterday, was because Shandong Weigao announced their results, and Its 50 % owned JW Medical System (JWMS for short) make a profit of 34,915 million RMB. THis is approximately equivalent to US$4.8m to US$5 m. (Depending on the FX rate used) If you compare with last qtr, Biosensors announced that their 50 % of JWMS profit was US$5.732 m of which US$2.6 m was a govt grant. IF THERE IS NO GOVT grant for this current Qtr, then JWMS is contributing actual earnings of US$4.8 m to US$5.00 m. If Terumo's licensing contribution remains constant at US$2.5 m, then Biosensors will have earned approx US$7.3 m to US$7.5m, just from external sources for the current Qtr. Also, their 9-mths earnings todate is approx US$22.9 m, implying that they would have already earned approx US$30m for the whole year, without considering their own sales. THis US$30m is closer to Nomura's projection of US$33m, rather than Credit Suisse projection of US$24.9 m. Above is my own estimates. For info - Not a call to buy/sell. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||
